At CFO (Boardroom Media) we track over 1,000,000 startups and over 5,000,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top United States based CFO’ operating in the Bioinformatics space. If you think a CFO’ is missing from this list, feel free to contact our editor on [email protected]
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Chief Financial Officer of Zymergen
Prior to joining Zymergen, Ena was focused on semiconductor investments at Mubadala, Abu Dhabi’s sovereign wealth fund. She spent the previous seven years in investment banking, initially at Salomon Smith Barney’s Latin America Group, later working for Merrill Lynch’s Technology Investment Banking Group. Ena studied at Cornell University and received her graduate degree at MIT Sloan School of Management.
Follow Enakshi Singh:
About Zymergen: Zymergen is a biotechnology company that specializes in machine learning, big data, and artificial intelligence.
Chief Financial Officer of CareGuardian
Senior financial executive with broad experience in corporate and business unit finance and operations, including in-depth knowledge of technology (SAAS), media, advertising and direct marketing models. – Experienced CFO and COO of both Public, Private Equity and Venture-backed entities. – Broad experience in mergers, acquisitions, and divestitures, as well as corporate debt and equity financing’s, including leading a successful IPO as Chief Financial Officer. – Record of accomplishment in leading organizations through rapid business expansions and contractions. – Extensive international experience – Expertise in the SEC, Sarbanes-Oxley and technical accounting requirements of multinational public companies.
Follow Thomas Etergino:
About CareGuardian: CareGuardian is significantly improving health outcomes through connected caregivers.
Founder & CFO of DataSet Analysis
Management, Financial operations, Tax, Treasury
Follow Olga Samarina:
About Barbary Coast Neighborhood Association, California Board of Accountancy, California Society of Certified Public Accountants, DataSet Analysis, The Bay Club, The Commonwealth Club of California, Trinity: DSA is an early stage medtech startup company that aims to bring research and diagnostics software to the business market.
CFO of AXON Connected
Follow Mory Watkins:
About AXON Connected, Surefire Local: AXON Connected commercializes technology.
Interim Chief Financial Officer of Kiromic Biopharma
On September 30, 2021, the Board of Directors of the Company appointed Dan Clark as interim Chief Financial Officer, effective September 30, 2021. Mr. Clark joined the Company in February 2020 and served as the Company’s Corporate Controller until September 2021, when he was promoted to Vice President – Finance Operations prior to his appointment as interim Chief Financial Officer. Before joining the Company, Mr. Clark was a Manager with The Siegfried Group, a national accounting services firm, from June 2018 to February 2020. Prior to his employment with The Siegfried Group, Mr. Clark served as Senior Consultant – Office of the CFO Solutions for FTI Consulting, a global financial consulting firm, from January 2017 to May 2018. Prior to that, Mr. Clark was Senior Associate – Audit at KPMG US, a member of Big Four global accounting firm KPMG, from August 2011 to June 2015.
Follow Daniel Clark:
About Kiromic Biopharma: Kiromic develops biomarker- and small molecule-based diagnostic and therapeutic programs for solid tumors and hematologic malignancies.